Purchase Order 75P00224P00105
Award Date
7/16/24
Potential Completion Date
8/15/24
Potential Value
$250K
Federal Agency
Office of the Assistant Secretary for Administration
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Glaxosmithkline, LLC, doing business as Glaxosmithkline, is for the acquisition and stockpiling of 277,632 packages of the antiviral medication Relenza (zanamivir) over a 12-month period. The $7,287,840.00 fixed-price delivery order was issued by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services. The contract supports disease prevention and preparedness efforts, with no...
This federal contract award to Glaxosmithkline, LLC (doing business as Glaxosmithkline) is for the purchase of 7,617 courses of the antiviral medication Zanamir (Relenza) at a firm fixed price of $17.37 per course, totaling $132,307.29. The award is from the Department of Homeland Security Countering Weapons of Mass Destruction program, with delivery required by October 31, 2018. The contract does not have a set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range...
<p>This is a Definitive Contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to GlaxoSmithKline Holdings (Americas) Inc. on September 30, 2009. The contract is for the purchase of the antiviral drug Relenza for the Strategic National Stockpile, with a ceiling value of $195,479,999.40 and a firm fixed price. The contract has no set-aside designation and is scheduled for completion on September 29, 2011.</p>
The Department of Homeland Security awarded a $516,000.00 firm fixed price purchase order to Glaxosmithkline, LLC for the provision of the antiviral medication zanamivir (Relenza) for the DHS antiviral stockpile. This contract did not use a set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antiviral medications, and other products to U.S. government agencies through federal contracts. The company has experience supporting disease prevention and...
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The $331,245.90 firm fixed price delivery order is for the antiviral medication zanamivir. There is no set-aside designation for this award. Glaxosmithkline has held other federal contracts and grants,...
This is a $157,500.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for the pharmaceutical product zanamivir for inhalation. The contract has a completion date of March 18, 2024 and was awarded on August 29, 2023. Glaxosmithkline is a major pharmaceutical company that provides a range of drugs and vaccines to U.S. government agencies through federal contracts and grants. This...
This federal contract award, SPE2DP16D0009/0020, was issued by the Defense Logistics Agency (DLA) to the prime contractor Glaxosmithkline, LLC. The $312,660.00 firm fixed price delivery order is for the antiviral medication zanamivir. The contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in North Carolina. Glaxosmithkline is a pharmaceutical company that provides vaccines, antivirals, and other products to various U.S. government agencies...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, to provide the antiviral medication zanamivir. The $263,537.64 contract has a completion date of December 6, 2017 and does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products to U.S. government agencies, including influenza vaccines, COVID-19 treatments, and other antiviral...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of the antiviral medication zanamivir. The contract has a ceiling value of $80,651.20 and a completion date of February 19, 2019. The contract is not set aside for any particular business type. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies, including the Departments...
This federal contract award, SPE2DP18D0010|SPE2DP18F5904, was issued by the Defense agency Medical Supply Chain to the prime contractor Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other products to U.S. government agencies. The contract is for the delivery of the antiviral medication zanamivir, with a total ceiling value of $92,628.80 and a completion date of February 19, 2019. The contract is a firm fixed price delivery order, with no...